Workflow
BOCIC(601696)
icon
Search documents
中银证券(601696) - 第二届董事会第四十一次会议决议公告
2025-10-30 09:59
中银国际证券股份有限公司 第二届董事会第四十一次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 中银国际证券股份有限公司(以下简称"公司")第二届董事会第四十一次会议于 2025 年 10 月 30 日以视频会议、通讯表决方式召开,会议通知于 2025 年 10 月 22 日以电 子邮件方式发出。本次会议应参与表决董事 12 名,实际参与表决董事 12 名。会议由董事 长周权先生主持,公司相关高级管理人员等列席会议。本次董事会会议的召集、召开符合 有关法律、行政法规、部门规章、规范性文件和《中银国际证券股份有限公司章程》的规 定。本次会议审议并通过以下议案: 一、审议通过《关于公司 2025 年第三季度报告的议案》 表决结果:同意【12】票;反对【0】票;弃权【0】票。 本议案具体内容详见公司于同日披露的《2025 年第三季度报告》。 本议案已经公司董事会审计委员会事前审议通过。 二、审议通过《关于修订<公司全面风险管理政策>的议案》 表决结果:同意【12】票;反对【0】票;弃权【0】票。 本议案已经公司董事会风 ...
中银证券(601696) - 2025年半年度权益分派实施公告
2025-10-30 09:59
证券代码:601696 证券简称:中银证券 公告编号:2025-049 中银国际证券股份有限公司 2025年半年度权益分派实施公告 相关日期 | 股份类别 | 股权登记日 | 最后交易日 | 除权(息)日 | 现金红利发放日 | | --- | --- | --- | --- | --- | | A股 | 2025/11/6 | - | 2025/11/7 | 2025/11/7 | 差异化分红送转: 否 一、 通过分配方案的股东会届次和日期 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 每股分配比例 A 股每股现金红利0.0204元(含税) 本次利润分配方案经公司2025 年 9 月 15 日的2025年第二次临时股东会审议通过。 二、 分配方案 截至股权登记日下午上海证券交易所收市后,在中国证券登记结算有限责任公司上海分 公司(以下简称"中国结算上海分公司")登记在册的本公司全体股东。 3. 分配方案: 本次利润分配以方案实施前的公司总股本2,778,000,000股为基数,每股派发现金红利 0.0204 ...
中银证券(601696) - 2025 Q3 - 季度财报
2025-10-30 09:50
Financial Performance - The company's operating revenue for the third quarter reached ¥933,209,992.19, representing a year-on-year increase of 38.33%[3] - Total profit for the quarter was ¥359,259,711.59, reflecting a growth of 34.88% compared to the same period last year[3] - Net profit attributable to shareholders was ¥289,029,399.70, which is an increase of 22.37% year-on-year[3] - The net profit after deducting non-recurring gains and losses was ¥288,954,422.62, showing a significant increase of 57.23% compared to the previous year[3] - The total operating revenue for the first nine months of 2025 reached CNY 2,438,281,894.72, an increase of 27% compared to CNY 1,920,670,513.38 in the same period of 2024[28] - Net interest income for the same period was CNY 690,954,789.65, up from CNY 587,645,818.39, reflecting a growth of approximately 17.6%[28] - Net commission and fee income increased to CNY 1,484,591,079.73, compared to CNY 1,029,415,011.58, marking a rise of about 44%[28] - The total profit for the first nine months was CNY 1,051,666,562.70, compared to CNY 749,986,315.77 in the previous year, indicating a growth of approximately 40%[28] - The net profit attributable to shareholders of the parent company was CNY 854,070,237.26, an increase from CNY 660,622,092.47, representing a growth of around 29%[28] - The company reported a total comprehensive income of CNY 885,228,813.84 for the first nine months of 2025, compared to CNY 686,552,232.23 in the same period of 2024, indicating an increase of approximately 29%[28] - Total comprehensive income attributable to the parent company reached ¥885,228,091.97, up from ¥686,474,948.81 in the previous year, representing a growth of approximately 28.9%[29] - Basic and diluted earnings per share increased to ¥0.31 from ¥0.24, reflecting a growth of 29.2% year-over-year[29] Assets and Liabilities - The total assets of the company at the end of the reporting period were ¥91,001,038,413.67, up 21.48% from the end of the previous year[4] - Total assets as of September 30, 2025, amounted to CNY 91,001,038,413.67, up from CNY 74,909,210,078.10, reflecting an increase of approximately 21%[24] - Total liabilities increased to CNY 72,293,482,235.52 from CNY 56,919,952,601.29, showing a growth of about 27%[24] - The net capital of the parent company increased to ¥16,014,977,324.85, compared to ¥15,310,899,889.39 at the end of the previous year[5] Cash Flow - The company reported a decrease of 31.69% in net cash flow from operating activities year-to-date, totaling ¥10,069,633,576.47[3] - Net cash flow from operating activities for the first three quarters of 2025 was ¥10,069,633,576.47, down 31.8% from ¥14,741,055,728.75 in the same period of 2024[30] - Cash inflow from operating activities totaled ¥17,400,499,722.51, a decrease of 16.5% compared to ¥20,783,725,723.15 in the previous year[30] - Net cash outflow from investing activities was ¥6,978,323,641.48, compared to a net outflow of ¥2,308,072,329.44 in the prior year, indicating increased investment expenditures[31] - Cash inflow from financing activities amounted to ¥8,024,390,000.00, an increase of 48.5% from ¥5,400,030,000.00 in the previous year[31] - The net cash flow from financing activities was positive at ¥3,028,907,000.73, contrasting with a negative flow of ¥1,704,115,500.55 in the same period last year[31] - The ending balance of cash and cash equivalents increased to ¥43,782,054,202.88, up from ¥37,798,982,091.20 in the previous year, marking a growth of 15.5%[31] - The company reported a significant decrease in cash received from operating activities related to securities trading, totaling ¥6,726,589,038.27, down from ¥10,150,983,882.06[30] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 147,576[10] - The top shareholder, Zhongyin International Holdings Limited, holds 33.42% of the shares, totaling 928,421,054 shares[10] Corporate Governance - The company appointed Mr. Zhou Quan as a director and chairman of the board, effective September 5, 2025[16] - The company has revised its articles of association and abolished the supervisory board as of September 5, 2025[18] Regulatory Compliance - The company received an administrative regulatory measure from the China Securities Regulatory Commission for compliance issues at its Hohhot branch[19] - The company officially revoked its securities business license for the Pingxiang Park Middle Road Securities Branch on August 11, 2025[20] Capital Management - The company approved a capital increase of CNY 1.4 billion to its wholly-owned subsidiary, raising its registered capital to CNY 2 billion[21] - The company renewed its appointment of Ernst & Young Hua Ming as the auditor for the 2025 financial year[22] Mergers and Acquisitions - The company did not report any net profit from merged entities during the current or previous periods, indicating no impact from mergers on earnings[29]
立讯精密股价跌5.16%,中银证券旗下1只基金重仓,持有5800股浮亏损失2.01万元
Xin Lang Cai Jing· 2025-10-30 06:26
Group 1 - Lixun Precision experienced a decline of 5.16% on October 30, with a stock price of 63.81 yuan per share and a trading volume of 9.882 billion yuan, resulting in a total market capitalization of 464.652 billion yuan [1] - The company, founded on May 24, 2004, and listed on September 15, 2010, specializes in the research, production, and sales of connectors, primarily serving the 3C (computer, communication, consumer electronics), automotive, and communication equipment sectors [1] - The revenue composition of Lixun Precision includes 78.55% from consumer electronics, 8.91% from communication interconnect products and precision components, 6.95% from automotive interconnect products and precision components, 3.93% from computer interconnect products and precision components, and 1.65% from other connectors and businesses [1] Group 2 - According to data, a fund under Bank of China Securities holds a significant position in Lixun Precision, with the Bank of China Securities Xinrui 6-Month Holding A (010170) reducing its holdings by 1,200 shares in the third quarter, now holding 5,800 shares, which represents 0.78% of the fund's net value [2] - The fund, established on November 11, 2020, has a latest scale of 32.9375 million yuan, with a year-to-date return of 3.23% and a one-year return of 5.12%, ranking 7,355 out of 8,152 and 7,001 out of 8,038 respectively [2]
杰普特股价涨5.05%,中银证券旗下1只基金重仓,持有1.72万股浮盈赚取13.9万元
Xin Lang Cai Jing· 2025-10-30 06:19
Group 1 - Jepter's stock price increased by 5.05% to 167.87 CNY per share, with a trading volume of 446 million CNY and a turnover rate of 2.87%, resulting in a total market capitalization of 15.956 billion CNY [1] - The stock has risen for four consecutive days, accumulating a total increase of 16.63% during this period [1] - Jepter specializes in the research, development, production, and sales of lasers and intelligent equipment for precision testing and micro-processing related to integrated circuits and semiconductor optoelectronic devices, with main business revenue composition being 53.32% from lasers, 38.19% from laser/optical intelligent equipment, and 1.81% from fiber optic devices [1] Group 2 - Zhongyin Securities holds Jepter as a top ten heavy stock in its fund, with the Zhongyin Securities New Energy Mixed A fund (005571) holding 17,200 shares, accounting for 4.28% of the fund's net value [2] - The fund has generated a floating profit of approximately 139,000 CNY today and 392,400 CNY during the four-day increase [2] - The Zhongyin Securities New Energy Mixed A fund was established on August 2, 2018, with a latest scale of 35.507 million CNY and a year-to-date return of 55.55%, ranking 968 out of 8,152 in its category [2]
仕佳光子股价跌5.06%,中银证券旗下1只基金重仓,持有4.5万股浮亏损失16.92万元
Xin Lang Cai Jing· 2025-10-30 03:09
Core Viewpoint - The stock of Shijia Photon has experienced a decline of 5.06%, with a current price of 70.51 CNY per share and a total market capitalization of 32.35 billion CNY [1] Company Overview - Shijia Photon Technology Co., Ltd. was established on October 26, 2010, and went public on August 12, 2020. The company is located in Hebi City, Henan Province [1] - The main business segments include optical chips and devices, indoor optical cables, and cable materials. Key products consist of PLC splitter chip series, AWG chip series, DFB laser chip series, optical fiber connectors, indoor optical cables, and cable materials [1] - Revenue composition is as follows: optical chips and devices account for 70.52%, indoor optical cables for 15.11%, cable polymer materials for 12.66%, and others for 1.72% [1] Fund Holdings - According to data, one fund under Bank of China Securities holds a significant position in Shijia Photon. The fund, Zhongyin Securities Preferred Industry Leader Mixed A (009640), held 45,000 shares in the third quarter, representing 3.55% of the fund's net value, making it the eighth-largest holding [2] - The fund has a total scale of 62.0185 million CNY and has achieved a return of 68.37% year-to-date, ranking 470 out of 8,152 in its category. Over the past year, it has returned 57.15%, ranking 809 out of 8,038 [2] Fund Manager Performance - The fund manager of Zhongyin Securities Preferred Industry Leader Mixed A is Song Fangyun, who has been in the position for 2 years and 312 days. The total asset scale of the fund is 90.4612 million CNY [3] - During the manager's tenure, the best fund return was 27.73%, while the worst return was -39.29% [3]
泽璟制药股价涨5.09%,中银证券旗下1只基金重仓,持有12.8万股浮盈赚取56.7万元
Xin Lang Cai Jing· 2025-10-30 02:29
Core Viewpoint - Zai Jian Pharmaceutical's stock increased by 5.09% to 91.43 CNY per share, with a trading volume of 279 million CNY and a market capitalization of 24.202 billion CNY as of October 30 [1] Company Overview - Suzhou Zai Jian Biopharmaceutical Co., Ltd. was established on March 18, 2009, and went public on January 23, 2020. The company focuses on the research, production, and sales of chemical and biological new drugs [1] - The main revenue composition of the company is 99.97% from pharmaceuticals, 0.02% from pharmaceutical intermediates and raw materials, and 0.00% from asset leasing [1] Fund Holdings - A fund under Bank of China Securities holds Zai Jian Pharmaceutical as one of its top ten holdings. The fund, Zhongyin Securities Health Industry Mixed Fund (002938), reduced its holdings by 4,000 shares in the third quarter, maintaining 128,000 shares, which accounts for 9.08% of the fund's net value, ranking it as the third-largest holding [2] - The fund has a total size of 159 million CNY and has achieved a year-to-date return of 39.48%, ranking 2223 out of 8152 in its category. Over the past year, it has returned 28.41%, ranking 3260 out of 8038, and since inception, it has returned 134.28% [2] Fund Manager Information - The fund manager of Zhongyin Securities Health Industry Mixed Fund (002938) is Li Mingwei, who has been in the position for 2 years and 252 days. The fund's total asset size is 159 million CNY, with the best and worst returns during his tenure being -5.4% [3]
骄成超声股价跌5.22%,中银证券旗下1只基金重仓,持有2.64万股浮亏损失15.91万元
Xin Lang Cai Jing· 2025-10-30 02:20
Group 1 - The core point of the news is that Jiao Cheng Ultrasonic experienced a decline of 5.22% in its stock price, reaching 109.41 CNY per share, with a total market capitalization of 12.662 billion CNY [1] - Jiao Cheng Ultrasonic, established on February 13, 2007, specializes in the research, design, production, and sales of ultrasonic welding and cutting equipment, as well as providing automation solutions for the new energy battery manufacturing sector [1] - The company's main business revenue composition includes: 31.42% from accessories, 25.86% from new energy battery ultrasonic equipment, 18.51% from services and others, 13.92% from harness connector ultrasonic equipment, 8.03% from semiconductor ultrasonic equipment, 2.09% from non-metal ultrasonic equipment, and 0.18% from other supplementary sources [1] Group 2 - According to data, a fund under Bank of China Securities holds a significant position in Jiao Cheng Ultrasonic, with the Bank of China New Energy Mixed A Fund (005571) owning 26,400 shares, accounting for 4.46% of the fund's net value, making it the eighth largest holding [2] - The Bank of China New Energy Mixed A Fund has reported a year-to-date return of 55.55%, ranking 968 out of 8152 in its category, and a one-year return of 50.14%, ranking 1177 out of 8038 [2]
股票行情快报:中银证券(601696)10月29日主力资金净买入1.21亿元
Sou Hu Cai Jing· 2025-10-29 14:00
Core Viewpoint - As of October 29, 2025, Zhongyin Securities (601696) closed at 14.73 yuan, marking a 2.43% increase, with a trading volume of 950,300 hands and a total transaction value of 1.393 billion yuan [1] Group 1: Stock Performance - On October 29, 2025, the net inflow of main funds was 121 million yuan, accounting for 8.67% of the total transaction value, while retail investors experienced a net outflow of 63.01 million yuan, representing 4.52% of the total transaction value [1] - The stock's performance over the past five days shows fluctuations in net fund flows, with notable changes in main, retail, and speculative funds [2] Group 2: Financial Metrics - Zhongyin Securities has a total market value of 40.92 billion yuan, ranking 67th in the industry, with a net asset of 18.535 billion yuan and a net profit of 565 million yuan, ranking 35th [3] - The company reported a year-on-year increase in main revenue of 20.79% to 1.505 billion yuan and a net profit increase of 33.13% to 565 million yuan for the first half of 2025 [3] - The company's second-quarter performance showed a main revenue of 753 million yuan, up 19.49% year-on-year, and a net profit of 285 million yuan, up 28.15% year-on-year [3] Group 3: Business Segments - Zhongyin Securities categorizes its business into investment banking, securities brokerage, asset management, proprietary trading, private equity investment, futures, and other services [3] - The company operates futures business through its wholly-owned subsidiary Zhongyin International Futures and private investment fund business through Zhongyin International Investment [3]
英华周播报|4000点得而复失,后市怎么看?创新药近期为何回调?
中国基金报· 2025-10-29 09:38
Group 1 - The article discusses the volatility in the gold market, highlighting the recent dramatic price fluctuations and their implications for investors [2] - It emphasizes the importance of having a long-term investment strategy, particularly in the context of technological advancements and market uncertainties [3] - The piece suggests that investors should focus on fundamental analysis and avoid excessive leverage in their investment decisions [5] Group 2 - The article mentions that certain segments of the non-ferrous metals market still show strong support despite recent market corrections [5] - It highlights the significance of education in personal finance, particularly regarding retirement planning, indicating that it is essential for all age groups [7] - The content also includes insights from fund managers on the high volatility of innovative pharmaceuticals and the potential for gold prices to continue rising [9][11]